CTRI/2025/04/083972尚未招募不适用
Characterizing gaps in the Pharmacologic Treatment of Childhood Migraine and its Association with Quality of Life: A Single-center Descriptive Study
Sarthak Joshi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月4日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To document the current acute and preventive pharmacologic treatment in children
研究概览
简要总结
We plan to analyze the current treatment practices in newly diagnosed
pediatric migraine patients using questionnaire method, compare them with the standard guidelines, and find the association between the treatment gaps and migraine severity. This may spur the pediatricians and neurologists in appropriately identifying and treating pediatric migraine
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •Children aged 6-12 years fulfilling the International Headache Society (ICHD-3) diagnostic criterion for migraine.
排除标准
- •Mixed headache Unable to read or understand either Hindi/English.
结局指标
主要结局
To document the current acute and preventive pharmacologic treatment in children
时间窗: At baseline.
newly diagnosed with migraine.
时间窗: At baseline.
次要结局
- To compare these treatment practices with the standard treatment guidelines, to identify(the gaps in treatment.)
- To analyze the association between the gaps in pharmacological treatment with the(quality of life of children with migraine.)
研究者
Dr Devendra Mishra
Maulana Azad Medical College
研究点 (1)
Loading locations...
相似试验
招募中
不适用
MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With MigrainePediatric MigraineMigraineNCT07419607Medical University Innsbruck30
已完成
4 期
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine TreatmentMigraineNCT07336420Theranica466
招募中
3 期
AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE2023-505601-16-00Pfizer Inc.80
尚未招募
2 期
Comparison of two drugs for reducing pain intensity in children with neuropathic painCTRI/2024/12/078718Prateek Kumar Panda40
招募中
1 期
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)MigraineCTIS2023-506253-38-00Eli Lilly & Co.1,338